The Early Events That Initiate β-Amyloid Aggregation in Alzheimer's Disease

被引:83
|
作者
Zhang, Xingyu [1 ]
Fu, Zhihui [1 ]
Meng, Lanxia [1 ]
He, Mingyang [1 ]
Zhang, Zhentao [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Neurol, Wuhan, Hubei, Peoples R China
来源
FRONTIERS IN AGING NEUROSCIENCE | 2018年 / 10卷
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; beta-amyloid; aggregation; age; diabetes; TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN APO E4; A-BETA; OXIDATIVE STRESS; HEAD-INJURY; DIABETES-MELLITUS; PRECURSOR PROTEIN; MOUSE MODEL; INFLAMMATORY S100A9; MICROGLIAL RESPONSE;
D O I
10.3389/fnagi.2018.00359
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Alzheimer's disease (AD) is characterized by the development of amyloid plaques and neurofibrillary tangles (NFTs) consisting of aggregated beta-amyloid (A beta) and tau, respectively. The amyloid hypothesis has been the predominant framework for research in AD for over two decades. According to this hypothesis, the accumulation of A beta in the brain is the primary factor initiating the pathogenesis of AD. However, it remains elusive what factors initiate A beta aggregation. Studies demonstrate that AD has multiple causes, including genetic and environmental factors. Furthermore, genetic factors, many age-related events and pathological conditions such as diabetes, traumatic brain injury (TBI) and aberrant microbiota also affect the aggregation of A beta. Here we provide an overview of the age-related early events and other pathological processes that precede A beta aggregation.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Screening for Novel Inhibitors of Amyloid Beta Aggregation and Toxicity as Potential Drugs for Alzheimer's Disease
    Sharari, Sanaa
    Vaikath, Nishant N.
    Tsakou, Magdalini
    Ghanem, Simona S.
    Vekrellis, Kostas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [32] Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer's Disease
    Re, F.
    Airoldi, C.
    Zona, C.
    Masserini, M.
    La Ferla, B.
    Quattrocchi, N.
    Nicotra, F.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (27) : 2990 - 3006
  • [33] The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome
    Drummond, Eleanor
    Kavanagh, Tomas
    Pires, Geoffrey
    Marta-Ariza, Mitchell
    Kanshin, Evgeny
    Nayak, Shruti
    Faustin, Arline
    Berdah, Valentin
    Ueberheide, Beatrix
    Wisniewski, Thomas
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2022, 10 (01)
  • [34] Alzheimer's Disease: A Molecular View of β-Amyloid Induced Morbific Events
    Asik, Rajmohamed Mohamed
    Suganthy, Natarajan
    Aarifa, Mohamed Asik
    Kumar, Arvind
    Szigeti, Krisztian
    Mathe, Domokos
    Gulyas, Balazs
    Archunan, Govindaraju
    Padmanabhan, Parasuraman
    BIOMEDICINES, 2021, 9 (09)
  • [35] Cardiometabolic Modification of Amyloid Beta in Alzheimer's Disease Pathology
    Hefner, Marleigh
    Baliga, Vineet
    Amphay, Kailinn
    Ramos, Daniela
    Hegde, Vijay
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [36] Amyloid-β oligomers in cellular models of Alzheimer's disease
    Fontana, Igor C.
    Zimmer, Aline R.
    Rocha, Andreia S.
    Gosmann, Grace
    Souza, Diogo O.
    Lourenco, Mychael, V
    Ferreira, Sergio T.
    Zimmer, Eduardo R.
    JOURNAL OF NEUROCHEMISTRY, 2020, 155 (04) : 348 - 369
  • [37] Absence of beta-amyloid in cortical cataracts of donors with and without Alzheimer's disease
    Michael, Ralph
    Rosandic, Jurja
    Montenegro, Gustavo A.
    Lobato, Elvira
    Tresserra, Francisco
    Barraquer, Rafael I.
    Vrensen, Gijs F. J. M.
    EXPERIMENTAL EYE RESEARCH, 2013, 106 : 5 - 13
  • [38] The Features of Beta-Amyloid Phosphorylation in Alzheimer's Disease
    Strelnikova, P. A.
    Bugrova, A. E.
    Zakharova, N. V.
    Danichkina, K. V.
    Indeykina, M. I.
    Gavrish, M. S.
    Krut, V. G.
    Babaev, A. A.
    Morozova, A. Yu.
    Kononikhin, A. S.
    Mitkevich, V. A.
    Makarov, A. A.
    Nikolaev, E. N.
    ACTA NATURAE, 2024, 16 (03): : 93 - 101
  • [39] Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
    Kametani, Fuyuki
    Hasegawa, Masato
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [40] THE ROLE OF β-AMYLOID AND MITOCHONDRIAL DYSFUNCTION IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE
    Szarka Andras
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2015, 68 (7-8): : 222 - 228